Literature DB >> 13804056

Effect of pyrimethamine upon sporogony and pre-erythrocytic schizogony of Laverania falciparum.

R S BRAY, R W BURGESS, R M FOX, M J MILLER.   

Abstract

Studies have been conducted in Liberia on the effect of pyrimethamine on the sporogony and, for the first time, on the pre-erythrocytic schizogony of Laverania falciparum. From the results reported here it is concluded that it may reasonably be assumed that a mass monthly regimen of pyrimethamine in Liberia could afford protection to the individual and to the mosquito and thus to the population at large, provided that resistance to pyrimethamine does not intervene.Pyrimethamine in single doses of 25 mg or 50 mg administered to gametocyte carriers was able to render gametocytes of L. falciparum uninfective to A. gambiae for periods up to 28 days after administration.Mosquitos feeding upon a malaria-free pyrimethamine-treated subject before or after feeding upon a non-treated gametocyte carrier became infected and sporozoites appeared in the salivary glands.Pyrimethamine administered in 12.5-mg doses 13 days before, 6 days before and 2 days after sporozoite infection or administered in 25-mg doses 35 days and 7 days before sporozoite infection disallowed the development of the pre-erythrocytic schizonts of L. falciparum in the livers of two chimpanzees.

Entities:  

Keywords:  ANTIMALARIALS/pharmacology; PLASMODIUM FALCIPARUM/pharmacology

Mesh:

Substances:

Year:  1959        PMID: 13804056      PMCID: PMC2537869     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  9 in total

1.  Further studies on malaria suppression by monthly drug administration.

Authors:  M J MILLER
Journal:  Am J Trop Med Hyg       Date:  1957-07       Impact factor: 2.345

2.  The treatment of Plasmodium falciparum infection with chloroquine, with a note on infectivity to mosquitoes of primaquine- and pyrimethamine-treated cases.

Authors:  G M JEFFERY; M D YOUNG; D E EYLES
Journal:  Am J Hyg       Date:  1956-07

3.  Resistance of East African varieties of Plasmodium falciparum to pyrimethamine.

Authors:  D F CLYDE; G T SHUTE
Journal:  Trans R Soc Trop Med Hyg       Date:  1954-11       Impact factor: 2.184

4.  The action of antimalarial drugs in mosquitoes infected with Plasmodium falciparum.

Authors:  L A TERZIAN; A B WEATHERSBY
Journal:  Am J Trop Med Hyg       Date:  1949-01       Impact factor: 2.345

5.  The action of antimalarial drugs in mosquitoes infected with Plasmodium gallinaceum.

Authors:  L A TERZIAN; N STAHLER; A B WEATHERSBY
Journal:  J Infect Dis       Date:  1949 Jan-Feb       Impact factor: 5.226

6.  Chemotherapeutic and other studies on the pre-erythrocytic forms of simian malaria (Plasmodium cynomolgi).

Authors:  F HAWKING; J P THURSTON
Journal:  Trans R Soc Trop Med Hyg       Date:  1952-05       Impact factor: 2.184

7.  Pyrimethamine resistance in Plasmodium vivax malaria.

Authors:  M D YOUNG; R W BURGESS
Journal:  Bull World Health Organ       Date:  1959       Impact factor: 9.408

8.  The development of pyrimethamine resistance by Plasmodium falciparum.

Authors:  R W BURGESS; M D YOUNG
Journal:  Bull World Health Organ       Date:  1959       Impact factor: 9.408

9.  The effect of pyrimethamine (daraprim) on the gametocytes and oocysts of Plasmodium falciparum and Plasmodium vivax.

Authors:  P G SHUTE; M MARYON
Journal:  Trans R Soc Trop Med Hyg       Date:  1954-01       Impact factor: 2.184

  9 in total
  8 in total

1.  The effect of a single dose of pyrimethamine and primaquine in combination upon gametocytes and sporogony of Laverania falcipara (Plasmodium falciparum) in Liberia.

Authors:  A E GUNDERS
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

2.  A checklist of parasites and commensals reported for the chimpanzee (Pan).

Authors:  B J Myers; R E Kuntz
Journal:  Primates       Date:  1972-12       Impact factor: 2.163

3.  Induction of antimalaria immunity by pyrimethamine prophylaxis during exposure to sporozoites is curtailed by parasite resistance.

Authors:  Johannes Friesen; Steffen Borrmann; Kai Matuschewski
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

Review 4.  Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination.

Authors:  Rashad Abdul-Ghani; John C Beier
Journal:  Parasitol Res       Date:  2014-09-04       Impact factor: 2.289

5.  The effect of a single dose of primaquine on the gametocytes, gametogony and sporogony of Laverania falciparum.

Authors:  R W BURGESS; R S BRAY
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

6.  HIV treatments reduce malaria liver stage burden in a non-human primate model of malaria infection at clinically relevant concentrations in vivo.

Authors:  Charlotte V Hobbs; Jillian Neal; Solomon Conteh; Liam Donnelly; Jingyang Chen; Kennan Marsh; Lynn Lambert; Sachy Orr-Gonzalez; Jessica Hinderer; Sara Healy; William Borkowsky; Scott R Penzak; Sumana Chakravarty; Stephen L Hoffman; Patrick E Duffy
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

7.  Differential infectivity of gametocytes after artemisinin-based combination therapy of uncomplicated falciparum malaria.

Authors:  Dinkorma T Ouologuem; Cheick O Kone; Bakary Fofana; Bakary Sidibe; Amadou H Togo; Demba Dembele; Sekou Toure; Sekou Koumare; Ousmane Toure; Issaka Sagara; Abdoulaye Toure; Adama Dao; Ogobara K Doumbo; Abdoulaye A Djimde
Journal:  Afr J Lab Med       Date:  2018-12-06

8.  Evidence that seasonal malaria chemoprevention with SPAQ influences blood and pre-erythrocytic stage antibody responses of Plasmodium falciparum infections in Niger.

Authors:  Lamine Mahaman Moustapha; Rafiou Adamou; Maman Laminou Ibrahim; Mariama Abdoulaye Louis Padounou; Abdoulaye Diallo; David Courtin; Jean Testa; Jean Louis Abdourahim Ndiaye
Journal:  Malar J       Date:  2021-01-01       Impact factor: 2.979

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.